StockVS

NYSE · Medical Instruments & Supplies · USD

AptarGroup, Inc. (ATR) Stock Analysis

AptarGroup, Inc. (ATR) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

ATR

$127.41

−$0.90 (−0.70%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ATR with… →

ATR Key Statistics

As of Sep 4, 2026
Trading
Open
$127.53
Previous Close
$128.31
Day's Range
126.53–128.47
52-Week Range
103.23–146.91
Volume
324.00K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.38
Valuation
Market Cap
$8.10B
P/E Ratio
23.17
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
20.17
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.68
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.06
EPS (ttm)Profit attributable to each share over the last twelve months.
5.50
Financials (FY)
Revenue (FY)
$3.78B+5.42%
Net Income (FY)
$392.79M+4.87%
Profit marginThe share of revenue left as profit after all costs and taxes.
9.22%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
63.58M
1-Year Return
−6.59%
Dividend and dates
Dividend
$1.92+1.51%
Ex-Dividend Date
July 30, 2026
Earnings Date
October 29, 2026
Avg Volume
457.05K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ATR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+5.66%
2025−21.40%
2024+28.60%
2023+13.89%
2022−8.93%
2021−9.54%
2020+19.87%
2019+24.47%
2018+10.55%
2017+19.32%
2016 (partial year)−3.15%

As of September 4, 2026.

ATR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$3.78B$392.79M10.4%
2024$3.58B$374.54M10.5%
2023$3.49B$284.49M8.2%
2022$3.32B$239.29M7.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.78B$1.40B$510.88M$392.79M10.4%
2024$3.58B$1.36B$509.50M$374.54M10.5%
2023$3.49B$1.26B$449.02M$284.49M8.2%
2022$3.32B$1.16B$385.87M$239.29M7.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ATR Dividend History

$1.83+6.4% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.443
2025$1.834+6.4%
2024$1.724+8.9%
2023$1.584+3.9%
YearDividends per sharePaymentsChange
2026 (partial year)$1.443
2025$1.834+6.4%
2024$1.724+8.9%
2023$1.584+3.9%
2022$1.524+1.3%
2021$1.504+4.2%
2020$1.444+1.4%
2019$1.424+7.6%
2018$1.324+3.1%
2017$1.284+300.0%
2016$0.321

Most recent payment: $0.48 per share, ex-dividend July 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ATR Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricATRMedical Instruments & Supplies medianvs median
P/E23.1735.6135% below
P/S ratio2.063.1735% below
Profit margin9.22%0.85%8.4 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values AptarGroup, Inc. (ATR) at $8.10B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 14,000 employees.

The 52-week range on file runs from $103.23 to $146.91. ATR last closed at $127.41 on September 4, 2026. That is −$0.90 (−0.70%) against the previous close. The latest close sits 23.42% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.78B. Against the prior fiscal year total of $3.58B, that is a change of +5.42%. The same year closed with net income of $392.79M. That is +4.87% against the prior fiscal year. The reported profit margin is 9.22%. That is 8.4 percentage points above the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are 5.5.

Across the 4 fiscal years on file, revenue moves from $3.32B in 2022 to $3.78B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 23.17 times earnings. That is 34.94% below the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 20.17. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.68. The price-to-sales ratio is 2.06. On price-to-sales that is 35.09% below the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −6.59%. Measured over 10 years, that is +6.28% a year compounded. Beta against the wider market is reported at 0.38. Annualized volatility over the trailing 10 years is 22.22%.

Growth & Income

The trailing dividend yield is 1.51%. That is 0.5 percentage points above the Medical Instruments & Supplies median yield of 0.97%. The indicated annual rate is $1.92 a share. The ex-dividend date on file is July 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.44 a share. The year before, 2025, totalled $1.83 a share.

Across the complete calendar years on file, 2024 returned +28.60% and 2025 returned −21.40%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is +5.66%.

Peer Comparison

AptarGroup, Inc. (ATR) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
AptarGroup, Inc. ATR $8.10B 23.2
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. AptarGroup, Inc. trades at a P/E of 23.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Visit website →